On December 12, 2025, Illinois Governor J.B. Pritzker signed Senate Bill 1950, commonly referred to as “Deb’s Law,” authorizing a medical aid-in-dying option for qualified terminally ill adults. Public reporting describes the framework as allowing eligible patients—generally those with a life expectancy of six months or less—to obtain medication that they self-administer, with the law taking effect in September 2026.
For MPL, new laws like this don’t just create a headline; they create a new clinical pathway, and new pathways create new allegation patterns. The biggest exposure isn’t typically “the medicine” so much as the process: eligibility confirmation, capacity assessments, documentation integrity, communications with family and care teams, and consistency across providers involved in end-of-life care. When the care decision sits at the intersection of ethics, regulation, and grief, claim frequency may not spike overnight, but severity and complexity can rise quickly if a case turns into a dispute over whether requirements were followed or whether a patient’s decision-making was properly evaluated.
GET THE SUMMIT
Sign up for news and stuff all about the stuff you wanna know about in your sector twice a month.
